| payload |
{"created_at":"2026-04-17T02:13:18.114 {"created_at":"2026-04-17T02:13:18.114675+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:a6aebae2508d57bd","evidence_event_ids":["evt_0b69cbb7f975"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1770787/0001610717-26-000145.txt","as_of":"2026-04-17T02:13:18.114675+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1770787/0001610717-26-000145.txt","company":"10x Genomics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1770787/0001610717-26-000145.txt","article_chars":2483,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_e021bc2de1b0b051","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1770787/0001610717-26-000145.txt","content_type":"text/plain","enriched_at":"2026-04-17T06:22:07.754457+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1770787/0001610717-26-000145.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1770787/0001610717-26-000145.txt","source_event_id":"evt_0b69cbb7f975","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"405377514ef6d0d3","kind":"sec_filing","published_at":"20260416","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-16","2026-04-14","2025-11-29","2019-03-15"],"entities":[{"asset_class":"equity","name":"10x Genomics, Inc.","relevance":"high","symbol":"TXG","type":"issuer"},{"asset_class":"equity","name":"Serge Saxonov","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"equity","name":"Andromeda Trust","relevance":"medium","symbol":"","type":"trust"},{"asset_class":"equity","name":"Y/S Descendants' Trust","relevance":"medium","symbol":"","type":"trust"},{"asset_class":"equity","name":"Y/S Pot Trust","relevance":"medium","symbol":"","type":"trust"}],"event_type":"other","information_gaps":["The filing text provided does not explicitly label whether the reported transaction is a sale vs. other transaction type beyond the described sale price language.","The filing excerpt does not clearly show the exact number of shares sold at each separate sale price (only that it can be provided upon request).","No prior-known state is included in the prompt, so the 'what changed vs prior known state' cannot be determined from the provided text alone."],"key_facts":["SEC filing type: Form 4.","Issuer: 10x Genomics, Inc. (TXG).","Reporting person: Serge Saxonov (Chief Executive Officer).","Conformed period of report (transaction date): 2026-04-14.","Filed as of date: 2026-04-16.","The transaction was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on November 29, 2025.","The transaction was executed in multiple trades at prices ranging from $24.49 to $24.70, inclusive.","The price reported reflects the weighted average sale price.","The shares are held by the Andromeda Trust, Y/S Descendants' Trust, and Y/S Pot Trust, for which the reporting person serves as trustee.","The filing includes an undertaking to provide full information regarding number of shares sold at each separate sale price upon request."],"numeric_claims":[{"label":"trade_price_min_usd","value":"24.49"},{"label":"trade_price_max_usd","value":"24.70"},{"label":"weighted_average_sale_price_usd","value":"24.5568"},{"label":"shares_sold","value":"5000"},{"label":"transaction_date","value":"2026-04-14"},{"label":"filing_date","value":"2026-04-16"}],"primary_claim":"Form 4 filed 2026-04-16 reports that Serge Saxonov sold 10x Genomics Class A Common Stock on 2026-04-14 under a Rule 10b5-1 trading plan, with trade prices ranging from $24.49 to $24.70.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"10x Genomics, Inc. (TXG) filed a Form 4 on 2026-04-16 disclosing that reporting person Serge Saxonov sold shares of Class A Common Stock on 2026-04-14 under a Rule 10b5-1 trading plan. The filing states the sale occurred in multiple trades at prices from $24.49 to $24.70 (weighted average sale price shown in the filing).","topics":["SEC Form 4","insider trading disclosure","Rule 10b5-1 trading plan","Class A Common Stock sales"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 10x Genomics, Inc. \u00b7 Filed 20260416","ticker":"TXG","tickers":["TXG"],"title":"TXG filed 4","url":"https://www.sec.gov/Archives/edgar/data/1770787/0001610717-26-000145.txt"}}... |